UPDATE 2-U.S. FDA clears new version of Abbott's low-cost glucose monitor
June 15, 2020 at 09:38 AM EDT
The U.S. Food and Drug Administration on Monday cleared a new version of Abbott Laboratories' continuous glucose monitoring device, helping the company build upon the success of its fastest-growing diabetes product.